Tetrabenazina (Spanish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Tetrabenazina" in Spanish language version.

refsWebsite

Global rank Spanish rank

2^nd place

2^nd place

low place

low place

274^th place

245^th place

doi.org

dx.doi.org

Gras, Domitille; Jonard, Laurence; Roze, Emmanuel; [Et al] (Octubre de 2012). «Benign hereditary chorea: phenotype, prognosis, therapeutic outcome and long term follow-up in a large series with new mutations in the TITF1/NKX2-1 gene». Journal of Neurology, Neurosurgery & Psychiatry 83 (10): 956-962. doi:10.1136/jnnp-2012-302505.
Jankovic, Joseph (Noviembre de 2016). «Dopamine depleters in the treatment of hyperkinetic movement disorders». Expert Opinion on Pharmacotherapy 17 (18): 2461-2470. doi:10.1080/14656566.2016.1258063.
Quezada, Julio; Coffman, Keith A. (Enero de 2018). «Current Approaches and New Developments in the Pharmacological Management of Tourette Syndrome». CNS Drugs 32 (1): 33-45. doi:10.1007/s40263-017-0486-0.
Ondo, William G. (Enero de 2012). «Tetrabenazine Treatment for Stereotypies and Tics Associated With Dementia». The Journal of Neuropsychiatry and Clinical Neurosciences 24 (2): 208-214. doi:10.1176/appi.neuropsych.11030077.
Chen, Jack J.; Ondo, William G.; Dashtipour, Khashayar; Swope, David M. (Julio de 2012). «Tetrabenazine for the Treatment of Hyperkinetic Movement Disorders: A Review of the Literature». Clinical Therapeutics 34 (7): 1487-1504. doi:10.1016/j.clinthera.2012.06.010.

doi.org

Gras, Domitille; Jonard, Laurence; Roze, Emmanuel; [Et al] (Octubre de 2012). «Benign hereditary chorea: phenotype, prognosis, therapeutic outcome and long term follow-up in a large series with new mutations in the TITF1/NKX2-1 gene». Journal of Neurology, Neurosurgery & Psychiatry 83 (10): 956-962. doi:10.1136/jnnp-2012-302505.
Jankovic, Joseph (Noviembre de 2016). «Dopamine depleters in the treatment of hyperkinetic movement disorders». Expert Opinion on Pharmacotherapy 17 (18): 2461-2470. doi:10.1080/14656566.2016.1258063.
Ondo, William G. (Enero de 2012). «Tetrabenazine Treatment for Stereotypies and Tics Associated With Dementia». The Journal of Neuropsychiatry and Clinical Neurosciences 24 (2): 208-214. doi:10.1176/appi.neuropsych.11030077.
Chen, Jack J.; Ondo, William G.; Dashtipour, Khashayar; Swope, David M. (Julio de 2012). «Tetrabenazine for the Treatment of Hyperkinetic Movement Disorders: A Review of the Literature». Clinical Therapeutics 34 (7): 1487-1504. doi:10.1016/j.clinthera.2012.06.010.

lundbeck.com

Valeant Pharmaceuticals North America LLC (2017). «Xenazine». Información para prescribir. TBZ-B-100001v2.

springer.com

link.springer.com

Quezada, Julio; Coffman, Keith A. (Enero de 2018). «Current Approaches and New Developments in the Pharmacological Management of Tourette Syndrome». CNS Drugs 32 (1): 33-45. doi:10.1007/s40263-017-0486-0.